Atrial myxomas arise from multipotent cardiac stem cells
Open Access
- 24 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (45), 4332-4345
- https://doi.org/10.1093/eurheartj/ehaa156
Abstract
Cardiac myxomas usually develop in the atria and consist of an acid-mucopolysaccharide-rich myxoid matrix with polygonal stromal cells scattered throughout. These human benign tumours are a valuable research model because of the rarity of cardiac tumours, their clinical presentation and uncertain origin. Here, we assessed whether multipotent cardiac stem/progenitor cells (CSCs) give rise to atrial myxoma tissue. Twenty-three myxomas were collected and analysed for the presence of multipotent CSCs. We detected myxoma cells positive for c-kit (c-kitpos) but very rare Isl-1 positive cells. Most of the c-kitpos cells were blood lineage-committed CD45pos/CD31pos cells. However, c-kitpos/CD45neg/CD31neg cardiac myxoma cells expressed stemness and cardiac progenitor cell transcription factors. Approximately ≤10% of the c-kitpos/CD45neg/CD31neg myxoma cells also expressed calretinin, a characteristic of myxoma stromal cells. In vitro, the c-kitpos/CD45neg/CD31neg myxoma cells secrete chondroitin-6-sulfate and hyaluronic acid, which are the main components of gelatinous myxoma matrix in vivo. In vitro, c-kitpos/CD45neg/CD31neg myxoma cells have stem cell properties being clonogenic, self-renewing, and sphere forming while exhibiting an abortive cardiac differentiation potential. Myxoma-derived CSCs possess a mRNA and microRNA transcriptome overall similar to normal myocardium-derived c-kitpos/CD45neg/CD31negCSCs , yet showing a relatively small and relevant fraction of dysregulated mRNA/miRNAs (miR-126-3p and miR-335-5p, in particular). Importantly, myxoma-derived CSCs but not normal myocardium-derived CSCs, seed human myxoma tumours in xenograft’s in immunodeficient NOD/SCID mice. Myxoma-derived c-kitpos/CD45neg/CD31neg CSCs fulfill the criteria expected of atrial myxoma-initiating stem cells. The transcriptome of these cells indicates that they belong to or are derived from the same lineage as the atrial multipotent c-kitpos/CD45neg/CD31neg CSCs. Taken together the data presented here suggest that human myxomas could be the first-described CSC-related human heart disease.Keywords
Funding Information
- Italian Association for Cancer Research
- AIRC (MFAG-2008, IG-23068)
- Ministry of Education, University and Research (PRIN2015 2015ZTT5KB_004)
- Futuro-in-Ricerca (RBFR12I3KA)
- Italian Ministry of Health Finalized Research (GR-2010-2318945)
- Regione Campania, POR Campania (FESR 2014/2020)
- Progetto GENOMAeSALUTE
- Medical Research Council (MR/P026508/1)
This publication has 59 references indexed in Scilit:
- MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung CancerCellular Physiology and Biochemistry, 2013
- Understanding cancer stem cell heterogeneity and plasticityCell Research, 2012
- Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kitPLOS ONE, 2011
- Determination of Somatic and Cancer Stem Cell Self-Renewing Symmetric Division Rate Using Sphere AssaysPLOS ONE, 2011
- Useful Immunohistochemical Markers of Tumor DifferentiationToxicologic Pathology, 2009
- miR-126 Regulates Angiogenic Signaling and Vascular IntegrityDevelopmental Cell, 2008
- The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and AngiogenesisDevelopmental Cell, 2008
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Sex distribution in cardiac myxomasThe American Journal of Cardiology, 2002
- Cardiac MyxomasThe New England Journal of Medicine, 1995